{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:11:56Z","timestamp":1793913116536,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-024-03386-y","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T09:33:54Z","timestamp":1732181634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The association between the use of angiotensin-converting enzyme inhibitors \/angiotensin receptor blockers and the development of ventilator-associated pneumonia in the intensive care unit: a retrospective cohort study"],"prefix":"10.1186","volume":"24","author":[{"given":"Hongfeng","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"issue":"1","key":"3386_CR1","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1186\/s12879-021-06383-2","volume":"21","author":"W Luo","year":"2021","unstructured":"Luo W, Xing R, Wang C. The effect of ventilator-associated pneumonia on the prognosis of intensive care unit patients within 90 days and 180 days. BMC Infect Dis. 2021;21(1):684.","journal-title":"BMC Infect Dis"},{"key":"3386_CR2","doi-asserted-by":"crossref","unstructured":"Arn Ng Q. Yew Shuen Ang C, Shiong Chiew Y, Wang X, Pin Tan C, Basri Mat Nor M, Salwa Damanhuri N, Geoffrey Chase J: CAREDAQ: Data acquisition device for mechanical ventilation waveform monitoring. HardwareX. 2022;12:e00358.","DOI":"10.1016\/j.ohx.2022.e00358"},{"issue":"2","key":"3386_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1055\/s-0041-1740605","volume":"43","author":"M Bassetti","year":"2022","unstructured":"Bassetti M, Mularoni A, Giacobbe DR, Castaldo N, Vena A. New Antibiotics for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia. Semin Respir Crit Care Med. 2022;43(2):280\u201394.","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"3386_CR4","doi-asserted-by":"publisher","first-page":"100320","DOI":"10.1016\/j.infpip.2023.100320","volume":"5","author":"C Semet","year":"2023","unstructured":"Semet C. The ongoing challenge of ventilator-associated pneumonia: epidemiology, prevention, and risk factors for mortality in a secondary care hospital intensive care unit. Infection Prevention in Practice. 2023;5(4):100320.","journal-title":"Infection Prevention in Practice"},{"issue":"2","key":"3386_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.2478\/jccm-2023-0012","volume":"9","author":"MJ Hasan","year":"2023","unstructured":"Hasan MJ, Sumi CD, Huq SMR, Anam AM, Rabbani R. Aerosolized Plus Intravenous Polymyxin B Versus Colistin in the Treatment of Pandrug-Resistant Klebsiella Pneumonia-mediated Ventilator-Associated Pneumonia: A Retrospective Cohort Study in Bangladesh. J Crit Care Med (Targu Mures). 2023;9(2):106\u201315.","journal-title":"J Crit Care Med (Targu Mures)"},{"issue":"11","key":"3386_CR6","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1017\/ice.2018.183","volume":"39","author":"PW Schreiber","year":"2018","unstructured":"Schreiber PW, Sax H, Wolfensberger A, Clack L, Kuster SP. The preventable proportion of healthcare-associated infections 2005\u20132016: Systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2018;39(11):1277\u201395.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"3386_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s12028-019-00773-w","volume":"32","author":"Y Li","year":"2020","unstructured":"Li Y, Liu C, Xiao W, Song T, Wang S. Incidence, Risk Factors, and Outcomes of Ventilator-Associated Pneumonia in Traumatic Brain Injury: A Meta-analysis. Neurocrit Care. 2020;32(1):272\u201385.","journal-title":"Neurocrit Care"},{"issue":"13","key":"3386_CR8","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.3390\/ijms21134709","volume":"21","author":"J Rysz","year":"2020","unstructured":"Rysz J, Franczyk B, Rysz-G\u00f3rzy\u0144ska M, Gluba-Brz\u00f3zka A. Pharmacogenomics of Hypertension Treatment. Int J Mol Sci. 2020;21(13):4709.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"3386_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.017297","volume":"9","author":"CF Christiansen","year":"2020","unstructured":"Christiansen CF, Heide-J\u00f8rgensen U, Rasmussen TB, Bodilsen J, S\u00f8gaard OS, Maeng M, Vistisen ST, Schmidt M, Potteg\u00e5rd A, Lund LC, et al. Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study. J Am Heart Assoc. 2020;9(19): e017297.","journal-title":"J Am Heart Assoc"},{"key":"3386_CR10","doi-asserted-by":"publisher","first-page":"600385","DOI":"10.3389\/fmed.2021.600385","volume":"8","author":"R ElAbd","year":"2021","unstructured":"ElAbd R, AlTarrah D, AlYouha S, Bastaki H, Almazeedi S, Al-Haddad M, Jamal M, AlSabah S. Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARB) Are Protective Against ICU Admission and Mortality for Patients With COVID-19 Disease. Front Med (Lausanne). 2021;8:600385.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"3386_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/phar.2677","volume":"42","author":"YP Fang","year":"2022","unstructured":"Fang YP, Zhang X. A propensity score-matching analysis of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker exposure on in-hospital mortality in patients with acute respiratory failure. Pharmacotherapy. 2022;42(5):387\u201396.","journal-title":"Pharmacotherapy"},{"key":"3386_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ajem.2022.10.006","volume":"62","author":"D Hasegawa","year":"2022","unstructured":"Hasegawa D, Lee YI, Prasitlumkum N, Chopra L, Nishida K, Smith RL, Sato R. Premorbid angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in patients with sepsis. Am J Emerg Med. 2022;62:69\u201377.","journal-title":"Am J Emerg Med"},{"issue":"10","key":"3386_CR13","doi-asserted-by":"publisher","first-page":"e14476","DOI":"10.1111\/ijcp.14476","volume":"75","author":"SY Lin","year":"2021","unstructured":"Lin SY, Chang SS, Lin CL, Lin CC, Hsu WH, Chou CH, Chi CY, Lin CD, Tu CY, Hsu CY, et al. Association between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and community-acquired pneumonia: A nationwide population propensity-score matching study. Int J Clin Pract. 2021;75(10):e14476.","journal-title":"Int J Clin Pract"},{"issue":"12","key":"3386_CR14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/phar.2739","volume":"42","author":"DP Alexander","year":"2022","unstructured":"Alexander DP, Nickman NA, Chhibber A, Stoddard GJ, Biskupiak JE, Munger MA. Angiotensin-converting enzyme inhibitors reduce community-acquired pneumonia hospitalization and mortality. Pharmacotherapy. 2022;42(12):890\u20137.","journal-title":"Pharmacotherapy"},{"issue":"10","key":"3386_CR15","doi-asserted-by":"publisher","first-page":"e110165","DOI":"10.1371\/journal.pone.0110165","volume":"9","author":"S Shah","year":"2014","unstructured":"Shah S, McArthur E, Farag A, Nartey M, Fleet JL, Knoll GA, Kim SJ, Garg AX, Jain AK. Risk of hospitalization for community acquired pneumonia with renin-angiotensin blockade in elderly patients: a population-based study. PLoS ONE. 2014;9(10):e110165.","journal-title":"PLoS ONE"},{"key":"3386_CR16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2147\/COPD.S158634","volume":"13","author":"CC Lai","year":"2018","unstructured":"Lai CC, Wang YH, Wang CY, Wang HC, Yu CJ, Chen L. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018;13:867\u201374.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"3386_CR17","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3390\/ijms23031772","volume":"23","author":"P Bryniarski","year":"2022","unstructured":"Bryniarski P, Nazimek K, Marcinkiewicz J. Immunomodulatory Activity of the Most Commonly Used Antihypertensive Drugs-Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers. Int J Mol Sci. 2022;23(3):1772.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3386_CR18","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1152\/japplphysiol.00514.2006","volume":"102","author":"JS Jiang","year":"2007","unstructured":"Jiang JS, Wang LF, Chou HC, Chen CM. Angiotensin-converting enzyme inhibitor captopril attenuates ventilator-induced lung injury in rats. J Appl Physiol (1985). 2007;102(6):2098\u2013103.","journal-title":"J Appl Physiol (1985)"},{"issue":"4","key":"3386_CR19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.healun.2011.12.012","volume":"31","author":"J Weber","year":"2012","unstructured":"Weber J, Tiriveedhi V, Takenaka M, Lu W, Hachem R, Trulock E, Patterson GA, Mohanakumar T. Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-\u03b1-dependant interleukin-17. J Heart Lung Transplant. 2012;31(4):419\u201326.","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"3386_CR20","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1097\/HJH.0b013e328357a87a","volume":"30","author":"CL Liu","year":"2012","unstructured":"Liu CL, Shau WY, Wu CS, Lai MS. Angiotensin-converting enzyme inhibitor\/angiotensin II receptor blockers and pneumonia risk among stroke patients. J Hypertens. 2012;30(11):2223\u20139.","journal-title":"J Hypertens"},{"issue":"4","key":"3386_CR21","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/mds.26136","volume":"30","author":"HC Wang","year":"2015","unstructured":"Wang HC, Lin CC, Lau CI, Chang A, Kao CH. Angiotensin-converting enzyme inhibitors and bacterial pneumonia in patients with Parkinson disease. Mov Disord. 2015;30(4):593\u20136.","journal-title":"Mov Disord"},{"issue":"6","key":"3386_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00228-008-0467-9","volume":"64","author":"PI Rafailidis","year":"2008","unstructured":"Rafailidis PI, Matthaiou DK, Varbobitis I, Falagas ME. Use of ACE inhibitors and risk of community-acquired pneumonia: a review. Eur J Clin Pharmacol. 2008;64(6):565\u201373.","journal-title":"Eur J Clin Pharmacol"},{"key":"3386_CR23","doi-asserted-by":"publisher","first-page":"9028969","DOI":"10.1155\/2022\/9028969","volume":"2022","author":"D Oosthuizen","year":"2022","unstructured":"Oosthuizen D, Sturrock ED. Exploring the Impact of ACE Inhibition in Immunity and Disease. J Renin Angiotensin Aldosterone Syst. 2022;2022:9028969.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"3386_CR24","doi-asserted-by":"crossref","unstructured":"Lopes RD, Macedo AVS, de Barros ESPGM, Moll-Bernardes RJ, Feldman A, D'Andr\u00e9a Saba Arruda G, de Souza AS, de Albuquerque DC, Mazza L, Santos MF et al. Continuing versus suspending angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: Impact on adverse outcomes in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)--The BRACE CORONA Trial. Am Heart J. 2020;226:49\u201359.","DOI":"10.1016\/j.ahj.2020.05.002"},{"issue":"14","key":"3386_CR25","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.3390\/ijms20143458","volume":"20","author":"IVG Silva","year":"2019","unstructured":"Silva IVG, de Figueiredo RC, Rios DRA. Effect of Different Classes of Antihypertensive Drugs on Endothelial Function and Inflammation. Int J Mol Sci. 2019;20(14):3458.","journal-title":"Int J Mol Sci"},{"key":"3386_CR26","doi-asserted-by":"publisher","first-page":"e4260","DOI":"10.1136\/bmj.e4260","volume":"345","author":"D Caldeira","year":"2012","unstructured":"Caldeira D, Alarc\u00e3o J, Vaz-Carneiro A, Costa J. Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: systematic review and meta-analysis. BMJ. 2012;345:e4260.","journal-title":"BMJ"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-024-03386-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-024-03386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T10:02:27Z","timestamp":1732183347000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-024-03386-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3386"],"URL":"https:\/\/doi.org\/10.1186\/s12890-024-03386-y","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]},"assertion":[{"value":"16 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement of ethical approval for this was waived by the Institutional Review Board of People\u2019s Hospital, Yanliang District, because the data was accessed from MIMIC-IV (a publicly available database). The need for written informed consent was waived by the Institutional Review Board of People\u2019s Hospital, Yanliang District due to retrospective nature of the study. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"578"}}